Friday, September 9, 2022

< + > Revance Shares Jump 18% After FDA Approves Botox Rival Daxxify

Revance Therapeutics says its new treatment, Daxxify, diminishes facial wrinkles for up to six months.

No comments:

Post a Comment

< + > The AI That Watches You Operate: Inside Stanford’s Breakthrough for Surgical Residents

I am always looking for unique, high-impact uses of AI in healthcare. While attending the annual Society of American Gastrointestinal and En...